scholarly journals What Is the Learning Curve for New Technologies in Total Joint Arthroplasty? A Review

2020 ◽  
Vol 13 (6) ◽  
pp. 675-679
Author(s):  
Nana O. Sarpong ◽  
Carl L. Herndon ◽  
Michael B. Held ◽  
Alexander L. Neuwirth ◽  
Thomas R. Hickernell ◽  
...  
2021 ◽  
Vol 17 (1) ◽  
pp. 51-58
Author(s):  
Eric N. Windsor ◽  
Abhinav K. Sharma ◽  
Ioannis Gkiatas ◽  
Ameer M. Elbuluk ◽  
Peter K. Sculco ◽  
...  

With the increase in technological advances over the years, telehealth services in orthopedic surgery have gained in popularity, yet adoption among surgeons has been slow. With the onset of the COVID-19 pandemic, however, orthopedic surgery practices nationwide have accelerated adaptation to telemedicine. Telehealth can be effectively applied to total joint arthroplasty, with the ability to perform preoperative consultations, postoperative follow-up, and telerehabilitation in a virtual, remote manner with similar outcomes to in-person visits. New technologies that have emerged, such as virtual goniometers, wearable sensors, and app-based patient questionnaires, have improved clinicians’ ability to conduct telehealth visits. Benefits of using telehealth include high patient satisfaction, cost-savings, increased access to care, and more efficiency. Notably, some challenges still exist, including widespread accessibility and adaptation of new technologies, inability to conduct an in-person orthopedic physical examination, and regulatory barriers, such as insurance reimbursement, increased medicolegal risk, and privacy and confidentiality concerns. Despite these hurdles, telehealth is here to stay and can be successfully incorporated in any total joint arthroplasty practice with the appropriate adjustments.


2018 ◽  
Vol 02 (02) ◽  
pp. 068-075 ◽  
Author(s):  
Noam Shohat ◽  
Javad Parvizi ◽  
Majd Tarabichi

AbstractPeriprosthetic joint infection (PJI) is a devastating mode of failure following total joint arthroplasty, imposing a serious burden on the healthcare system and society at large. Increasing demand for elective arthroplasty, as well as independent predictions demonstrating future rise in the prevalence of PJI, will lead to an increasing financial burden imposed by this dreadful complication. This challenge is further compounded by disturbing trends, such as drug-resistant organisms among others as a cause of PJI. The aim of this review is to provide the latest updates in the diagnosis of PJI, with a view to identifying areas in need of further research.


Author(s):  
D. Alex Stroh ◽  
Kimona Issa ◽  
Samik Banerjee ◽  
Jesse Allert ◽  
Eiman Shafa ◽  
...  

2014 ◽  
Vol 29 (6) ◽  
pp. 1083-1086.e1 ◽  
Author(s):  
Ran Schwarzkopf ◽  
Duy L. Phan ◽  
Melinda Hoang ◽  
Steven D.K. Ross ◽  
Dana Mukamel

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Christiane Schwerdt ◽  
Eric Röhner ◽  
Sabrina Böhle ◽  
Benjamin Jacob ◽  
Georg Matziolis

AbstractOne of the most challenging complications of total knee arthroplasty (TKA) is periprosthetic joint infection (PJI). There is growing evidence of a good anti-infective effect of intrawound vancomycin powder in total joint arthroplasty. At the same time, various different locally applied substances have become popular in total joint arthroplasty. The objective of this study was therefore to investigate a possible inhibition of the bactericidal effect of vancomycin by tranexamic acid, adrenalin, lidocaine, or dexamethasone. The bactericidal effect of vancomycin was quantified using the established method of the agar diffusion test. The plates were incubated with Staphylococcus aureus or Staphylococcus epidermidis and four wells were stamped out. The wells were filled with vancomycin alone, the tested substance alone or a mixture of the two. The fourth well remained empty as a control. The plates were incubated overnight at 37 °C and the zone of inhibition in each field was measured on the next day. All tests were run three times for each pathogen and mean values and standard deviations of the measurements were calculated. Differences between the substances were tested using the t-test at a level of significance of 0.05. The bacterial growth was homogeneous on all plates. The baseline value for the zone of inhibition of vancomycin was on average 6.2 ± 0.4 mm for Staphylococcus aureus and 12 ± 0.3 mm for Staphylococcus epidermidis. In all other substances, no inhibition was detected around the well. The combination of vancomycin and each other substance did not show any different result compared to vancomycin alone. The bactericidal effect of vancomycin on staphylococci is not altered by tranexamic acid, adrenalin, dexamethasone, or lidocaine in vitro.


Sign in / Sign up

Export Citation Format

Share Document